Last Updated: 21/12/2023
Technical consultation to review the effectiveness of rectal artesunate used as pre-referral treatment of severe malaria in children
Source(s):
Published: 21/06/2023
Technical consultation to review the effectiveness of rectal artesunate used as pre-referral treatment of severe malaria in children
WHO has recommended rectal artesunate (RAS) as an effective pre-referral treatment for severe malaria since 2006. On 18-19 October 2022, WHO convened a meeting with independent experts to review the evidence from effectiveness studies of RAS and develop guidance for the safe and effective implementation of this intervention.
External reference
Related Resources
Related Projects
No related items found
